Analyst Ratings for Nektar Therapeutics (NKTR )
NKTR Rating Summary
NKTR Price Target Summary
- Highest: $192.00 (Piper Sandler)
- Lowest: $95.00 (Wedbush)
- Average: $155.13
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$155.13 (+139.2%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
Avg. $ Target:
$155.13 (+139.2%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/24/2026 | Wedbush » Updated 4/20/2026 |
Martin Fan | New Coverage | Neutral (N/A) |
95.00 (70.00) |
74.34 (64.84) |
-12.78% | Details |
| 3/17/2026 | TD Cowen | Marc Frahm | New Coverage | Buy (N/A) |
N/A (N/A) |
72.21 (64.84) |
-10.21% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
